EUVIMEDEUVIMED entdecken
Open Access

ATF3 aggravates kidney fibrosis via HDAC6-dependent epigenetic reprogramming

Sibei Tao, Chenzhou Wu, Fanyuan Yu, Lina Yang, Lingzhi Li, Fan Guo, Ting Xiang, Liang Ma, Ping Fu

International Journal of Biological Sciences · 2026

DOI: 10.7150/ijbs.125062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Biological Sciences, 2026. Verfasst von Sibei Tao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China. Hauptthemen laut MEDLINE: Fibrosis, Activating Transcription Factor 3, Histone Deacetylase 6, Epigenesis, Genetic. Die Arbeit wurde bisher 4-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kidney fibrosis is the most common pathology and endpoint of CKD. Unraveling the mechanisms of kidney fibrosis is crucial. Activating transcription factors (ATFs) are implicated in a range of kidney diseases, but their roles in kidney fibrosis remain underexplored. In our investigation, employing an unbiased screening of ATF expression in fibrotic kidneys via analyzing single-cell and bulk RNA sequencing, we identified that ATF3 as the key player, markedly upregulated in damaged tubular epithelial cells (TECs). Crucially, ATF3 deletion in mice markedly attenuated kidney fibrosis and abrogated fibrotic traits in injured TECs. At the molecular level, ATF3 was found to recruit HDAC6 to the SMAD7 promoter, eradicating histone 3 lysine 14 acetylation (H3K14ac) and diminishing SMAD7 transcription. This interaction between ATF3 and HDAC6 culminated in the suppression of Smad7, triggering the TGF-β/Smad3 pathway and exacerbating kidney fibrosis. Collectively, our findings shed light on the complex underpinnings of kidney fibrosis and herald novel therapeutic targets for combating CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FibrosisActivating Transcription Factor 3Histone Deacetylase 6Epigenesis, GeneticKidneyKidney DiseasesAnimalsMiceSmad7 ProteinSmad3 ProteinEpithelial CellsSignal TransductionTransforming Growth Factor beta

Stichwörter der Autor:innen

ATF3HDAC6epigenetic reprogrammingkidney fibrosis

Substanzen

Activating Transcription Factor 3Histone Deacetylase 6Smad7 ProteinSmad3 ProteinAtf3 protein, mouseHdac6 protein, mouseTransforming Growth Factor betaSmad3 protein, mouseSmad7 protein, mouse

Autor:innen und Institutionen

  • Division of Nephrology, Kidney Research Institute, West China Hospital, Sichuan University, Chengdu 610041, Sichuan, China.
  • State Key Laboratory of Oral Diseases & National Center for Stomatology & National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu 610041, Sichuan, China.

Zitieren

APA

Tao, S., Wu, C., Yu, F., Yang, L., Li, L., Guo, F., Xiang, T., Ma, L., & Fu, P. (2026). ATF3 aggravates kidney fibrosis via HDAC6-dependent epigenetic reprogramming. International Journal of Biological Sciences. https://doi.org/10.7150/ijbs.125062

Vancouver

Tao S, Wu C, Yu F, Yang L, Li L, Guo F, et al. ATF3 aggravates kidney fibrosis via HDAC6-dependent epigenetic reprogramming. International Journal of Biological Sciences. 2026. doi:10.7150/ijbs.125062

BibTeX
@article{Tao2026,
  author = {Tao, Sibei and Wu, Chenzhou and Yu, Fanyuan and Yang, Lina and Li, Lingzhi and Guo, Fan and Xiang, Ting and Ma, Liang and Fu, Ping},
  title = {ATF3 aggravates kidney fibrosis via HDAC6-dependent epigenetic reprogramming},
  journal = {International Journal of Biological Sciences},
  year = {2026},
  doi = {10.7150/ijbs.125062}
}
Kostenlos starten →